nifedipine has been researched along with Cancer of Pituitary in 32 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 5.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| "Mastoparan has been reported to induce a wide variety of cellular actions by activating GTP-binding proteins (G proteins) in various cells." | 1.30 | Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins. ( Ito, H; Kawashima, S; Uchino, K; Yajima, Y, 1997) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 1.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| "Maitotoxin has been reported to activate calcium channels and stimulate calcium-dependent functions in several tissues, but a thorough investigation of 45Ca2+ fluxes is lacking." | 1.27 | The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells. ( Cronin, MJ; Judd, AM; Koike, K; Login, IS; MacLeod, RM; Schettini, G; Yasumoto, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (40.63) | 18.7374 |
| 1990's | 15 (46.88) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulayeva, NN | 1 |
| Wozniak, AL | 1 |
| Lash, LL | 1 |
| Watson, CS | 1 |
| Dominguez, B | 1 |
| Felix, R | 1 |
| Monjaraz, E | 1 |
| Enyeart, JJ | 3 |
| Hinkle, PM | 3 |
| Albert, PR | 1 |
| Tashjian, AH | 1 |
| De Vries, GW | 1 |
| McLaughlin, A | 1 |
| Wenzel, MB | 1 |
| Perez, J | 1 |
| Harcourt, D | 1 |
| Lee, G | 1 |
| Garst, M | 1 |
| Wheeler, LA | 1 |
| Levitan, ES | 1 |
| Gealy, R | 1 |
| Trimmer, JS | 1 |
| Takimoto, K | 1 |
| Gross, RA | 1 |
| Huggenvik, J | 1 |
| Massa, E | 1 |
| Allen, RG | 1 |
| Uhler, MD | 1 |
| Clark, TP | 1 |
| Kemppainen, RJ | 1 |
| Inukai, T | 1 |
| Wang, X | 1 |
| Greer, SE | 4 |
| Greer, MA | 4 |
| Yajima, Y | 1 |
| Uchino, K | 1 |
| Ito, H | 1 |
| Kawashima, S | 1 |
| Yin, J | 2 |
| Deng, J | 2 |
| Shi, Y | 2 |
| Shu, C | 1 |
| Kwiecien, R | 1 |
| Robert, C | 1 |
| Cannon, R | 1 |
| Vigues, S | 1 |
| Arnoux, A | 1 |
| Kordon, C | 1 |
| Hammond, C | 1 |
| Motoyoshi, S | 1 |
| Shirotani, T | 1 |
| Araki, E | 1 |
| Sakai, K | 1 |
| Kaneko, K | 1 |
| Motoshima, H | 1 |
| Yoshizato, K | 1 |
| Shirakami, A | 1 |
| Kishikawa, H | 1 |
| Shichiri, M | 1 |
| Cely, CM | 1 |
| Contreras, G | 1 |
| Lo, YK | 1 |
| Wu, SN | 1 |
| Lee, CT | 1 |
| Li, HF | 1 |
| Chiang, HT | 1 |
| Demura, R | 1 |
| Naruse, M | 1 |
| Isawa, M | 1 |
| Onoda, N | 1 |
| Naruse, K | 1 |
| Yamakado, M | 1 |
| Demura, H | 1 |
| Sato, N | 3 |
| Wang, XB | 3 |
| McAdams, S | 3 |
| Sei, CA | 1 |
| Glembotski, CC | 1 |
| Oshima, T | 1 |
| Cronin, MJ | 2 |
| Anderson, JM | 1 |
| Rogol, AD | 1 |
| Koritnik, DR | 1 |
| Thorner, MO | 1 |
| Evans, WS | 1 |
| Heisler, S | 2 |
| Aizawa, T | 2 |
| Gershengorn, MC | 2 |
| Thaw, CN | 1 |
| Geras-Raaka, E | 1 |
| Login, IS | 1 |
| Judd, AM | 1 |
| Koike, K | 1 |
| Schettini, G | 1 |
| Yasumoto, T | 1 |
| MacLeod, RM | 1 |
| Shangold, GA | 1 |
| Kongsamut, S | 1 |
| Miller, RJ | 1 |
| Luini, A | 1 |
| Corda, D | 1 |
| Axelrod, J | 1 |
| Wolfe, SE | 1 |
| Brostrom, CO | 1 |
| Brostrom, MA | 1 |
| Thaw, C | 1 |
32 other studies available for nifedipine and Cancer of Pituitary
| Article | Year |
|---|---|
Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line.
Topics: Animals; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Dr | 2005 |
Ghrelin and GHRP-6 enhance electrical and secretory activity in GC somatotropes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2007 |
The calcium agonist Bay K 8644 stimulates secretion from a pituitary cell line.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1984 |
Relationship of thyrotropin-releasing hormone-induced spike and plateau phases in cytosolic free Ca2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine.
Topics: Animals; Calcium; Cell Line; Cytosol; Ethers; Growth Hormone; Ionomycin; Kinetics; Nifedipine; Pitui | 1984 |
The antiinflammatory activity of topically applied novel calcium-channel antagonists.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calci | 1995 |
Membrane depolarization inhibits Kv1.5 voltage-gated K+ channel gene transcription and protein expression in pituitary cells.
Topics: Amiloride; Animals; Calcium; Clone Cells; Down-Regulation; Gene Expression; Kv1.5 Potassium Channel; | 1995 |
Genetic alteration of cyclic adenosine 3',5'-monophosphate-dependent protein kinase subunit expression affects calcium currents and beta-endorphin release in AtT-20 clonal pituitary cells.
Topics: Adrenocorticotropic Hormone; Allosteric Site; Animals; beta-Endorphin; Binding Sites; Calcium; Calci | 1994 |
Glucocorticoid negative feedback in sheep corticotrophs: a comparison with AtT-20 corticotroph tumor cells.
Topics: Adrenocorticotropic Hormone; Animals; Dexamethasone; Feedback; Glucocorticoids; Male; Nifedipine; Os | 1994 |
Adenosine 3',5'-cyclic monophosphate-mediated prolactin secretion in GH4C1 cells involves Ca2+ influx through L-type Ca2+ channels.
Topics: Adenylyl Cyclases; Animals; Bucladesine; Calcium; Calcium Channels; Colforsin; Cyclic AMP; Dose-Resp | 1993 |
Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.
Topics: Animals; Calcium; Calcium Channel Blockers; Cyclic AMP; Exocytosis; GTP-Binding Proteins; Inositol P | 1997 |
[The role of Ca2+ in the pathogenesis of human pituitary GH-secreting adenomas].
Topics: Adenoma; Biological Transport, Active; Calcimycin; Calcium; Calcium Channel Blockers; Growth Hormone | 1996 |
The role of calcium ion in the pathogenesis of human pituitary GH-secreting adenomas.
Topics: Adenoma; Biological Transport, Active; Calcium; Calcium Channel Blockers; Growth Hormone; Growth Hor | 1996 |
Endogenous pacemaker activity of rat tumour somatotrophs.
Topics: Action Potentials; Animals; Antisense Elements (Genetics); Apamin; Barium; Biological Clocks; Cadmiu | 1998 |
Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
Topics: Adenoma; Calcium Channel Blockers; Corticotropin-Releasing Hormone; Diazoxide; Gene Expression; Gluc | 1998 |
Approach to the patient with hypertension, unexplained hypokalemia, and metabolic alkalosis.
Topics: Adenoma; Adrenalectomy; Aldosterone; Alkalosis; Antihypertensive Agents; Diagnosis, Differential; Hu | 2001 |
Characterization of action potential waveform-evoked L-type calcium currents in pituitary GH3 cells.
Topics: Action Potentials; Adenoma; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Da | 2001 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoc | 1992 |
Evidence that ethanol induces prolactin secretion in GH4C1 cells by producing cell swelling with resultant calcium influx.
Topics: Animals; Calcium; Cell Line; Ethanol; Kinetics; Mannitol; Nifedipine; Osmolar Concentration; Pituita | 1990 |
Calcium dependence of phenylephrine-, endothelin-, and potassium chloride-stimulated atrial natriuretic factor secretion from long term primary neonatal rat atrial cardiocytes.
Topics: Adrenocorticotropic Hormone; Animals; Animals, Newborn; Atrial Function; Atrial Natriuretic Factor; | 1990 |
The permeant molecule urea stimulates prolactin secretion in GH4C1 cells by inducing Ca2+ influx through dihydropyridine-sensitive Ca2+ channels.
Topics: Animals; Calcium; Calcium Channels; Nifedipine; Osmolar Concentration; Pituitary Neoplasms; Prolacti | 1990 |
Medium hyposmolarity stimulates prolactin secretion in GH4C1 cells by inducing an increase in cytosolic free calcium.
Topics: Animals; Calcium; Cell Line; Culture Media; Cytosol; Hypotonic Solutions; Kinetics; Nifedipine; Pitu | 1990 |
Calcium channel agonist BAY k8644 enhances anterior pituitary secretion in rat and monkey.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Stimulation of adrenocorticotropin secretion from AtT-20 cells by the calcium channel activator, BAY-K-8644, and its inhibition by somatostatin and carbachol.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Interaction of dihydropyridine Ca2+ agonist Bay K 8644 with normal and transformed pituitary cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
BAY-K-8644-stimulated cyclic GMP synthesis in mouse pituitary tumor cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
Benzodiazepines modulate voltage-sensitive calcium channels in GH3 pituitary cells at sites distinct from thyrotropin-releasing hormone receptors.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Calcium; Cell Line; Chlordiazepoxide; Diazepam; Dil | 1988 |
The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells.
Topics: Animals; Calcium; Cell Line; Gallopamil; Growth Hormone; Ion Channels; Manganese; Marine Toxins; Nif | 1985 |
Characterization of voltage-sensitive calcium channels in a clonal pituitary cell line.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1985 |
Secretagogues elevate cytosolic calcium by stimulating cyclic AMP formation in a corticotropin secreting cell line.
Topics: Adrenocorticotropic Hormone; Animals; Calcium; Cell Line; Cyclic AMP; Cytosol; Mice; Nifedipine; Pit | 1985 |
Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation.
Topics: Acetylcholine; Amino Acids; Animals; Bromocriptine; Calcium; Carbachol; Cell Line; Chlorpromazine; I | 1986 |
Thyrotropin-releasing hormone (TRH) stimulates biphasic elevation of cytoplasmic free calcium in GH3 cells. Further evidence that TRH mobilizes cellular and extracellular Ca2+.
Topics: Aminoquinolines; Animals; Calcium; Cell Line; Cytoplasm; Extracellular Space; Fluorescent Dyes; Nife | 1985 |
Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
Topics: Animals; Calcium Channel Blockers; Cell Line; Growth Hormone; Nicotinic Acids; Nifedipine; Nimodipin | 1985 |